The LEADCORP, Inc. (KOSDAQ:012700)
South Korea · Delayed Price · Currency is KRW 3,555.00
+45.00 (1.28%)
At close: Feb 3, 2026
The LEADCORP Revenue
The LEADCORP had revenue of 104.76B KRW in the quarter ending September 30, 2025, a decrease of -1.48%. This brings the company's revenue in the last twelve months to 367.17B, down -22.49% year-over-year. In the year 2024, The LEADCORP had annual revenue of 420.48B, down -14.29%.
Revenue (ttm)
367.17B
Revenue Growth
-22.49%
P/S Ratio
0.26
Revenue / Employee
1.97B
Employees
186
Market Cap
94.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 420.48B | -70.09B | -14.29% |
| Dec 31, 2023 | 490.57B | -144.65B | -22.77% |
| Dec 31, 2022 | 635.22B | 142.76B | 28.99% |
| Dec 31, 2021 | 492.45B | 119.25B | 31.95% |
| Dec 31, 2020 | 373.20B | -122.16B | -24.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wooree Bio Co.,Ltd | 1.08T |
| KAON Group | 518.12B |
| Daehan Nupharm | 201.59B |
| UNITEKNO Co.,Ltd | 108.14B |
| Daejung Chemicals & Metals | 104.05B |
| Assems | 62.19B |
| Cell Biotech | 50.65B |
| GIANTSTEP | 41.06B |